Fractyl Health Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Fractyl Health, Inc. (GUTS) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-68.69-77.09-46.45-38.74-30.48
Depreciation & Amortization0.680.290.450.680.77
Stock Based Compensation14.434.303.142.091.63
Change in Working Capital9.590.99-1.241.71-3.51
Change in Accounts Receivable0.02-0.020.000.000.00
Change in Inventory0.00-0.070.000.000.00
Change in Accounts Payable2.69-0.430.010.67-0.30
Change in Other Working Capital6.881.51-1.251.05-3.20
Other Operating Activities-21.5226.73-2.140.790.52
Net Cash from Operating Activities-65.52-42.82-46.24-33.46-31.07
Investing Activities
Capital Expenditures-1.77-0.36-0.06-0.050.00
Net Cash from Investing Activities-1.77-0.36-0.06-0.050.00
Financing Activities
Debt Repayment-0.19-0.08-16.05-0.010.00
Common Stock Issued103.700.050.320.040.02
Other Financing Activities-2.28-0.960.00-0.150.00
Net Cash from Financing Activities101.2327.444.3599.8854.39
Summary
Net Change in Cash33.94-15.75-41.9566.3723.32
Cash at Beginning of Period37.7853.5295.4729.110.00
Cash at End of Period71.7237.7853.5295.470.00
Free Cash Flow-67.29-43.18-46.30-33.51-31.08
Supplemental Disclosures
Interest Paid3.130.760.011.031.04